Warsaw, Poland

Maria Mazur

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Adamed Pharma S.a.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Mazur. Retrieved from https://idiyas.com/inventor/maria-mazur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Mazur - Innovator in Therapeutic Compounds

Introduction

Maria Mazur is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that activate TP53, a crucial protein in cancer prevention and treatment.

Latest Patents

Maria holds a patent for her invention titled "1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-C]pyrrole]-2,3'-dione compounds as therapeutic agents activating TP53." This invention relates to compounds represented by a specific formula, which can be utilized in the prevention and treatment of various diseases, including cancer, immune diseases, inflammatory conditions, and viral infections. She has 1 patent to her name.

Career Highlights

Maria is currently employed at Adamed Pharma S.A., where she continues to innovate and develop new therapeutic solutions. Her work is instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Maria collaborates with notable colleagues, including Marcin Feder and Iwona Kalinowska, who contribute to her research and development efforts.

Conclusion

Maria Mazur is a dedicated inventor whose work in therapeutic compounds has the potential to make a significant impact in the medical field. Her innovative spirit and collaboration with talented professionals highlight her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…